PDUFA V: What you need to know about the upcoming Prescription Drug User Fee Act
Rho
News from AAPS 2010 | |
 |
The Outsourcing-pharma team went to the American Association of Pharmaceutical Scientists (AAPS) conference in New Orleans, US to cover all the breaking drug industry news and trends and speak with key pharmaceutical industry movers and shakers. For the full list of articles click the + More button below |
Molecular Profiles expands into early-development
UK contract research organization (CRO) Molecular Profiles says speed to clinical is key demand driver for drug development sector.
WuXi posts strong Q3; highlights GLP tox services at AAPS
Demand for drug discovery, development services and active pharmaceutical ingredients (APIs) were the main growth drivers in Q3 according to Wuxi Pharmatech.
SCM talks US demand for niche contracting at AAPS
SCM Pharma says demand for specialised contract manufacturing services is growing as the pharma industry focuses on niche indications, biologics and the development of potent medicines.
New analytical services biz plans growth in tough market
Newly-formed Gateway Analytical is confident its service offering, employees’ experience and ties to its parent company will allow it to grow despite a challenging operating environment.
Industry, innovation & Viagra-stuffed teddies at AAPS
Last week everything from co-processed excipients to Viagra-stuffed teddies were discussed at AAPS 2010. Now, with the show having finished, we present our personal take on the event.
Icon inks Proteome deal to bolster biomarker offering
Icon is adding protein and peptide profiling to its biomarker capabilities through a strategic alliance with Proteome Sciences.
Quotient and Bend discuss new collaboration at AAPS
Quotient Clinical and Bend Research have teamed up to tackle solubility issues in early clinical development.
PRA unveils new US bioanalytical lab at AAPS
PRA International says its new bioanalytical services laboratory in Lenexa, Kansas offers clinical customers streamlined services.
Spotlight
  Marken mulls direct-to-study participant distributionMarken is looking at setting up a home delivery service as a further expansion of its clinical... |